Authorized Generics’ Impact On Medicaid Pricing To Be Focus Of HHS Study
Executive Summary
The HHS Inspector General will initiate a study in fiscal 2006 examining the effect of authorized generics on Medicaid drug pricing and rebates
You may also be interested in...
Brand/Generic Deals Stay In FTC’s Crosshairs As It Seeks Legal Ammunition
The Federal Trade Commission will not remain complacent as brand and generic companies accelerate the pace and expand the boundaries of settlements, Commissioner Jon Leibowitz said
Brand/Generic Deals Stay In FTC’s Crosshairs As It Seeks Legal Ammunition
The Federal Trade Commission will not remain complacent as brand and generic companies accelerate the pace and expand the boundaries of settlements, Commissioner Jon Leibowitz said
Medicaid Reform Bill Is A Draw For Pharma; Pharmacy Continues Its Fight
The conference report on budget reconciliation creates a new definition of the Medicaid federal upper limit for pharmacy reimbursement for multiple source drugs